Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	129.06	71.55	23.87	27.27	28.02	31.81
Cash & Short-Term Investments	129.06	71.55	23.87	27.27	28.02	31.81
Cash Growth	65.69%	199.71%	-12.47%	-2.68%	-11.89%	-35.52%
Accounts Receivable	11.8	7.34	8.47	4.7	12.12	6.96
Receivables	11.8	7.34	8.47	4.7	12.12	6.96
Inventory	7.88	6.04	6.77	5.78	4.04	2.46
Prepaid Expenses	2.93	3.29	1.85	2.13	3.08	3.4
Total Current Assets	151.67	88.22	40.97	39.89	47.26	44.63
Property, Plant & Equipment	8.69	8.98	9.74	9.3	7.78	10.32
Other Intangible Assets	-	-	1.28	1.44	0.05	0.1
Other Long-Term Assets	3.2	4.22	5.44	6.45	6.9	7.84
Total Assets	163.56	101.42	57.42	57.07	61.99	62.88
Accounts Payable	10.87	10.29	8.93	9.95	8.31	7.09
Accrued Expenses	5.69	5.99	6.5	7.97	8.74	8.57
Current Portion of Long-Term Debt	6.33	0.03	0.02	18.7	2.03	2.58
Current Portion of Leases	0.6	0.51	0.39	0.26	0.9	0.73
Current Unearned Revenue	2.09	2.05	2.47	2.66	1.99	2.14
Total Current Liabilities	25.57	18.87	18.31	39.53	21.96	21.1
Long-Term Debt	29.82	32.35	27.34	33.45	51.55	34.33
Long-Term Leases	4.63	5.11	5.57	5.09	1.95	2.85
Long-Term Unearned Revenue	81.64	82.72	95.91	95.53	66.18	51.16
Other Long-Term Liabilities	26.01	22.52	16.78	2.03	2.49	1.95
Total Liabilities	167.67	161.58	163.91	175.62	144.13	111.38
Common Stock	0.12	0.09	0.07	0.06	0.04	0.04
Additional Paid-In Capital	410.91	302.97	212.52	192.6	174.62	137.73
Retained Earnings	-415.14	-363.21	-319.08	-311.21	-256.8	-186.26
Total Common Equity	-4.11	-60.16	-106.49	-118.55	-82.13	-48.5
Shareholders' Equity	-4.11	-60.16	-106.49	-118.55	-82.13	-48.5
Total Liabilities & Equity	163.56	101.42	57.42	57.07	61.99	62.88
Total Debt	41.38	38	33.32	57.49	56.42	40.48
Net Cash (Debt)	87.69	33.54	-9.45	-30.22	-28.4	-8.67
Net Cash Per Share	0.88	0.39	-0.15	-0.62	-0.75	-0.26
Filing Date Shares Outstanding	122	98.87	73.3	55.87	41.47	36.21
Total Common Shares Outstanding	121.66	91.41	68.53	54.83	41.23	34.57
Working Capital	126.1	69.36	22.66	0.36	25.3	23.52
Book Value Per Share	-0.03	-0.66	-1.55	-2.16	-1.99	-1.40
Tangible Book Value	-4.11	-60.16	-107.77	-119.99	-82.19	-48.6
Tangible Book Value Per Share	-0.03	-0.66	-1.57	-2.19	-1.99	-1.41
Machinery	23.98	23.77	23.64	23.21	22.49	25.54
Construction In Progress	2.42	2.11	2.03	1.47	1.16	0.88
Leasehold Improvements	21.42	21.42	21.39	21.38	21.27	21.33

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q